LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.410
0.00 (0.00%)
At close: Apr 28, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 49.70 million as of April 28, 2026. Its market cap has increased by 28.41% in one year.
Market Cap
49.70M
Enterprise Value
71.30M
Revenue
26.80M
Ranking
n/a
PE Ratio
18.07
Stock Price
0.41
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 49.70M, a decrease of -19.41%. That is a compound annual growth rate of -6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 49.70M | 17.14% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C21 Investments | 45.96M |
| ZYUS Life Sciences | 41.87M |
| Leef Brands | 59.90M |
| Rubicon Organics | 37.17M |
| BioNxt Solutions | 64.80M |
| Planet 13 Holdings | 65.65M |
| iAnthus Capital Holdings | 34.86M |
| Optimi Health | 34.84M |